Gene · 5216
Papers2,319
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,319
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of miR-330-3p and BMI1 Expression in Colorectal Cancer Patients, Healthy Adjacent Tissues, and Polypoid Adenomatous Lesions. | Int J Mol Cell Med | 2022 | 37727645 | PubTator, text mining | PubMed |
| A pilot study of the relative number of circulating tumor cells and leukocytes containing actin-binding proteins in head and neck cancer patients. | J Biomed Res | 2022 | 37226274 | PubTator, text mining | PubMed |
| Role of microglia autophagy and mitophagy in age-related neurodegenerative diseases. | Front Aging Neurosci | 2022 | 37180741 | PubTator, text mining | PubMed |
| Nanotechnology-based drug delivery for the treatment of CNS disorders. | Transl Neurosci | 2022 | 36741545 | PubTator, text mining | PubMed |
| Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas. | Front Immunol | 2022 | 36703985 | PubTator, text mining | PubMed |
| Long-Term Sleep Deprivation-Induced Myocardial Remodeling and Mitochondrial Dysfunction in Mice Were Attenuated by Lipoic Acid and N-Acetylcysteine. | Pharmaceuticals (Basel) | 2022 | 36678548 | PubTator, text mining | PubMed |
| Heritability of Protein and Metabolite Biomarkers Associated with COVID-19 Severity: A Metabolomics and Proteomics Analysis. | Biomolecules | 2022 | 36671431 | PubTator, text mining | PubMed |
| Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis. | AIMS Neurosci | 2022 | 36660079 | PubTator, text mining | PubMed |
Amyotrophic Lateral Sclerosis Pathoetiology and Pathophysiology: Roles of Astrocytes, Gut Microbiome, and Muscle Interactions via the Mitochondrial Melatonergic Pathway, with Disruption by Glyphosate-Based Herbicides. | Int J Mol Sci | 2022 | 36614029 | PubTator, text mining | PubMed |
| Fine-grained, nonlinear registration of live cell movies reveals spatiotemporal organization of diffuse molecular processes. | PLoS Comput Biol | 2022 | 36584219 | PubTator, text mining | PubMed |
| A novel TFG variant of uncertain significance in amyotrophic lateral sclerosis: A case report and review of literature. | Ann Med Surg (Lond) | 2022 | 36582889 | PubTator, text mining | PubMed |
| The sirtuin family in health and disease. | Signal Transduct Target Ther | 2022 | 36581622 | PubTator, text mining | PubMed |
| Traditional Herbal Medicine: A Potential Therapeutic Approach for Adjuvant Treatment of Non-small Cell Lung Cancer in the Future. | Integr Cancer Ther | 2022 | 36567455 | PubTator, text mining | PubMed |
| The Biological Effect of Small Extracellular Vesicles on Colorectal Cancer Metastasis. | Cells | 2022 | 36552835 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta. | Mol Med | 2022 | 36536281 | PubTator, text mining | PubMed |
| Biomarkers in psoriatic arthritis: A meta-analysis and systematic review. | Front Immunol | 2022 | 36532039 | PubTator, text mining | PubMed |
| Evaluation of serum proteome from Indian psoriasis patients. | Bioinformation | 2022 | 36518145 | PubTator, text mining | PubMed |
| Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation. | Front Immunol | 2022 | 36505452 | PubTator, text mining | PubMed |
| NSC Physiological Features in Spinal Muscular Atrophy: SMN Deficiency Effects on Neurogenesis. | Int J Mol Sci | 2022 | 36499528 | PubTator, text mining | PubMed |
| OMICS Approaches Evaluating Keloid and Hypertrophic Scars. | Int J Inflam | 2022 | 36483731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5216/papers?page=18